Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audited Financial Results For The Quarter And Nine Months Ended 31St December 2023

Audited Financial Results for the quarter and nine months ended 31st December 2023
06-02-2024
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - CEP Certificate For Losartan Potassium Issued By EDQM

We wish to inform you that European Directorate for Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Losartan Potassium on 5th February 2024. This will enable the Company to export Losartan Potassium in European Market. Losartan is a drug used for treatment of hypertension.
06-02-2024
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Intimation for Notice Of The Board Meeting

IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and nine months ended 31st December 2023 and declaration of Interim Dividend, if any, for the Financial Year 2023-2024.
29-01-2024
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018
09-01-2024
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window

Notice of closure of Trading Window
27-12-2023
Next Page
Close

Let's Open Free Demat Account